TetraLogic Pharmaceuticals (TLOG) - Financial and Strategic SWOT Analysis Review

  • ID: 4278389
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 3
TetraLogic Pharmaceuticals (TetraLogic) is a biopharmaceutical company that research and develops novel small molecule therapeutics in the areas of oncology and infectious diseases. The company’s clinical stage products include birinapant and SHAPE. Its birinapant is a small molecule therapeutic that causes cell death in damaged cells and is used in the treatment of hematological malignancies and solid tumors. TetraLogic carries out clinical trial to investigate the safety and effectiveness of different dosing regimens of SHAPE in patients suffering from earlier stage cutaneous T-cell lymphoma. The company conducts research and development to develop products for blood cancers, ovarian cancers, myelodysplastic syndromes, cutaneous T-cell lymphoma, hepatitis B and infectious diseases. TetraLogic is headquartered in Malvern, Pennsylvania, the US.

This comprehensive SWOT profile of TetraLogic Pharmaceuticals provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by the Author to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the Author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the Author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of TetraLogic Pharmaceuticals including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 3
Section 1 - About the Company

TetraLogic Pharmaceuticals - Key Information
TetraLogic Pharmaceuticals - Overview
TetraLogic Pharmaceuticals - Key Employees
TetraLogic Pharmaceuticals - Key Employee Biographies
TetraLogic Pharmaceuticals - Key Operational Heads
TetraLogic Pharmaceuticals - Major Products and Services
TetraLogic Pharmaceuticals - History
TetraLogic Pharmaceuticals - Company Statement
TetraLogic Pharmaceuticals - Locations And Subsidiaries
TetraLogic Pharmaceuticals - Key Manufacturing facilities Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

TetraLogic Pharmaceuticals - Business Description
TetraLogic Pharmaceuticals - Corporate Strategy
TetraLogic Pharmaceuticals - SWOT Analysis
SWOT Analysis - Overview
TetraLogic Pharmaceuticals - Strengths
TetraLogic Pharmaceuticals - Weaknesses
TetraLogic Pharmaceuticals - Opportunities
TetraLogic Pharmaceuticals - Threats
TetraLogic Pharmaceuticals - Key Competitors

Section 3 - Company Financial Performance Charts

TetraLogic Pharmaceuticals - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Ratio Definitions
About Us
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

TetraLogic Pharmaceuticals, Key Information
TetraLogic Pharmaceuticals, Key Ratios
TetraLogic Pharmaceuticals, Share Data
TetraLogic Pharmaceuticals, Major Products and Services
TetraLogic Pharmaceuticals, History
TetraLogic Pharmaceuticals, Key Employees
TetraLogic Pharmaceuticals, Key Employee Biographies
TetraLogic Pharmaceuticals, Key Operational Heads
TetraLogic Pharmaceuticals, Other Locations
TetraLogic Pharmaceuticals, Subsidiaries
TetraLogic Pharmaceuticals, Key Manufacturing facilities
TetraLogic Pharmaceuticals, Key Competitors
TetraLogic Pharmaceuticals, SWOT Analysis
TetraLogic Pharmaceuticals, Ratios based on current share price
TetraLogic Pharmaceuticals, Annual Ratios
TetraLogic Pharmaceuticals, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

TetraLogic Pharmaceuticals, Performance Chart
TetraLogic Pharmaceuticals, Ratio Charts
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown